Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
48 /100
MEDIUM RISK
Score updated Aug 28, 2026

RGNX — REGENXBIO Inc. Dilution Risk Tracker

Track RGNX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGNX — Get alerts when the score changes →

As of August 28, 2026, REGENXBIO Inc. (RGNX) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. REGENXBIO Inc. has a market capitalization of $362.40M, 66.01M shares outstanding, 180 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $150.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
36
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 16%
💰 Capital Raise model 33%
• Under 12 months cash (7mo)
• Active ATM program with $150M remaining capacity
🔔 Track RGNX — Get forecast alerts →

Market Data

Market Cap$362.40M
Shares Outstanding66.01M
Float43.10M
Cash$105.52M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.3% shares (2026Q1 vs prior)
180 institutional holders · 52.42M shares
#1 MORGAN STANLEY 5.79M shares
#2 BlackRock, Inc. 5.78M shares
#3 Redmile Group, LLC 4.37M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.19M
Days to Cover3.8
% of Float16.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2015-12-31
424B5 ATM 2026-02-12
4 INSIDER TRANSACTION 2026-02-03
4 INSIDER TRANSACTION 2026-02-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RGNX Dilution Snapshot

REGENXBIO Inc. (RGNX) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RGNX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGNX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RGNX
RGNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.